Effect of configuration of muramyl dipeptide glycoside bond and structure of glycoside aglycon on their capacity to stimulate production of interleukin-1 and tumor necrosis factor by macrophages

Bulletin of Experimental Biology and Medicine

Volumn 134, Issue 3, 2002, Pages 281-283

  Kalyuzhin, O V ^a   Nelyubov, M V ^a   Kalyuzhina, E V ^a   Kuzovlev, F N ^a   Shkalev, M V ^a  

^a RESEARCH INSTITUTE OF HUMAN MORPHOLOGY   (Russian Federation)

Author keywords

Interleukin 1; Muramyl dipeptide glycosides; Tumor necrosis factor

Indexed keywords

GLYCOSIDE; INTERLEUKIN 1; MURAMYL DIPEPTIDE; MURAMYL DIPEPTIDE DERIVATIVE; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINE ADAMANTYLGLYCOSIDE; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINE BUTYLGLYCOSIDE; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINE CYCLOHEXYGLYCOSIDE; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINE CYCLOHEXYLGLYCOSIDE; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINE GLYCOSIDE DERIVATIVE; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINE HEPTYLGLYCOSIDE; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINE HEXYLGLYCOSIDE; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINE NAPHTHYLGLYCOSIDE; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINE OCTYLGLYCOSIDE; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINE PHENETHYGLYCOSIDE; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINE PHENYLGLYCOSIDE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; IMMUNOMODULATION; IMMUNOSTIMULATION; IN VITRO STUDY; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; REGULATORY MECHANISM; STIMULATION; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

ACETYLMURAMYL-ALANYL-ISOGLUTAMINE; ADJUVANTS, IMMUNOLOGIC; ANIMALS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; GLYCOSIDES; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; MACROPHAGES; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 0036770651     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021519921125     Document Type: Article

References (11)

1. A. E. Zemlyakov, Muramylpeptides: Synthesis and Biological Activity, Abstract of Doct. Chem. Sci. Dissertation, Odessa (2000).
2. O. V. Kalyuzhin, A. E. Zemlyakov, E. V. Kalyuzhina, et al., Byull. Eksp. Biol. Med., 134, No. 8, 186-190 (2002).
3. O. V. Kalyuzhin and A. V. Karaulov, Progress in Clinical Immunology and Allergology, Ed. A. V. Karaulov [in Russian], Vo. 1, Moscow (2000), pp. 252-258.
4. S. A. Ketlinskii, A. S. Simbirtsev, and A. A. Vorob'ev, Endogenous Immunomodulators [in Russian], St. Petersburg (1992).
5. B. B. Fuks, A. L. Rakhmilevich, A. A. Pimenov, and A. G. Dubrovskaya, Byull. Eksp. Biol. Med., 104, No. 10, 497-499 (1987).
6. H. Fish and G. E. Gifford, Int. J. Cancer, 32, 105-112 (1983).
7. O. V. Kalyuzhin, A. E. Zemlyakov, and B. B. Fuchs, Int. J. Immunopharmacol., 18, No. 11, 651-659 (1996).
8. J. A. Kern, J. C. Reed, R. P. Daniele, et al., J. Immunol., 137, 764-771 (1986).
9. S. Kotani, I. Azuma, H. Tacada, et al. Biological Response Modifiers in Human Oncology and Immunology, Eds. T. Klein et al., New York (1983), pp. 117-158.
10. D. Lovett, B. Kozan, M. Hadam, et al., J. Immunol., 136, 340-347 (1986).
11. T. Uede, Y. Kocda, Y. Ibayashi, et al., Ibid., 135, 1343-1351.